Our mission is to fund research with the highest probability of preventing, slowing or reversing Alzheimer's Disease through venture based philanthropy. All organizational expenses are paid for by the Founders and Board, allowing all other contributions to be applied directly to Alzheimer's Disease research.
Each of GlobalGiving’s nonprofit partners is required to send quarterly donor reports detailing the impact of their work. Here are some of their recent updates:
By Laurel Lyle | VP-Philanthropy Operations
When we think of the side effects of treatments or medications, our minds may naturally turn to negative side effects, like nausea or headaches. But sometimes a side effect proves beneficial.... Read the full report ›By Laurel Lyle | VP-Development Operations
In an effort to understand how the pathology of Alzheimer’s disease spreads through the brain, scientists meticulously mapped the genetic activity of 1.3 million cells across six regions of the... Read the full report ›By Laurel Lyle | VP-Development Operations
In the brain, accumulation of abnormal tau is one component of the destructive pathology leading to Alzheimer’s disease. Throughout our lifetime, microglia are the resident innate immune cells... Read the full report ›
